glp-1 drugs depression tied to lower brain inflammation, higher risk GLP-1s associated with reduced risk

For those studying multi-pathway metabolic modulation, retatrutide offers a unique research tool

QC and Method Transfer: Reproducibility and Robustness Routine Quality Control (QC) workflows face unique burdens with peptide analysis

Renal effects of dpp-4 inhibitor sitagliptin or glp-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial

Its that you dont really want it in the first place

doi: 10.1042/BCJ20170736

By calculating each patients long-term risk and alerting their primary healthcare providers when necessary, labs can help those providers make better decisions at the point of care